Foxy-5
Tier C — Watch / tradeFoxy-5
Targets：WNT5A
Indications (approved)：Colon cancer, Prostate cancer, Metastatic breast cancer, Colorectal cancer
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| Foxy-5-001 | 71989-18-9 | (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoic acid |
| Foxy-5-002 | 2748-02-9 | tert-butyl L-leucinate hydrochloride |
| Foxy-5-003 | 200936-59-0 | tert-butyl (S)-4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-(((S)-1-(tert-butoxy)-4-methyl-1-oxopentan-2-yl)amino)-5-oxopentanoate |
| Foxy-5-004 | 2412026-00-5 | tert-butyl (5R,8S,11S)-8-(3-(tert-butoxy)-3-oxopropyl)-1-(9H-fluoren-9-yl)-11-isobutyl-3,6,9-trioxo-5-((tritylthio)methyl)-2-oxa-4,7,10-triazadodecan-12-oate |
| Foxy-5-005 | 2412025-97-7 | tert-butyl (8R,11S,14S)-11-(3-(tert-butoxy)-3-oxopropyl)-1-(9H-fluoren-9-yl)-14-isobutyl-3,6,9,12-tetraoxo-8-((tritylthio)methyl)-2-oxa-4,7,10,13-tetraazapentadecan-15-oate |
| Foxy-5-006 | 2412026-01-6 | di-tert-butyl (2S,5S,8R,14S)-14-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-(3-(tert-butoxy)-3-oxopropyl)-2-isobutyl-4,7,10,13-tetraoxo-8-((tritylthio)methyl)-3,6,9,12-tetraazahexadecanedioate |
| Foxy-5-007 | 2412025-98-8 | di-tert-butyl (2S,5S,8R,14S)-14-((S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-4-(methylthio)butanamido)-5-(3-(tert-butoxy)-3-oxopropyl)-2-isobutyl-4,7,10,13-tetraoxo-8-((tritylthio)methyl)-3,6,9,12-tetraazahexadecanedioate |
| Foxy-5-008 | 2412025-99-9 | di-tert-butyl (2S,5S,8R,14S)-5-(3-(tert-butoxy)-3-oxopropyl)-14-((S)-2-formamido-4-(methylthio)butanamido)-2-isobutyl-4,7,10,13-tetraoxo-8-((tritylthio)methyl)-3,6,9,12-tetraazahexadecanedioate |
Frequently asked questions
What are the approved indications of Foxy-5?
Approved indications include: Colon cancer, Prostate cancer, Metastatic breast cancer, Colorectal cancer.
When does the Foxy-5 patent expire?
No public expiry year is available for Foxy-5 yet; this page updates once verified.
How many synthesis routes are recorded for Foxy-5?
1 synthesis routes are recorded; the shortest is 7 steps with 12.3 g (Foxy-5) total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Foxy-5 intermediates?
All intermediates in Foxy-5 routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Foxy-5 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-08